AwardTape · Defense awards · Research and development · Defense systems R&D · HDTRA124C0003
HDTRA124C0003: $3.5M definitive contract to Genecapture, Inc
Genecapture, Inc holds a definitive contract from Defense Threat Reduction Agency with $3.5M obligated since Oct 2023, against a ceiling of $4.5M. Latest action Jan 6, 2026.
Infectious disease diagnostics and differentiation of viral vs. bacterial infections for point of care applications (phase iii)
| PIID | HDTRA124C0003 |
|---|---|
| Type | definitive contract |
| Company | Genecapture, Inc |
| Agency | Defense Threat Reduction Agency |
| Contracting office | DEFENSE THREAT REDUCTION AGENCY |
| Category | Research and development · Defense systems R&D |
| PSC | AC33 NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $3.5M |
| Total obligated (lifetime) | $3.5M |
| Ceiling (base and all options) | $4.5M |
| Base date | Nov 2, 2023 |
| Latest action | Jan 6, 2026 |
| End date | Jul 31, 2026 |
| Actions since Oct 2023 | 7 |
| Pricing | Cost plus fixed fee |
| Competition | Full and open competition |
| Place of performance | AL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial